Skip to main content
Clinical Trials/NCT05537441
NCT05537441
Completed
Not Applicable

Precision Vaccine Promotion in Underserved Populations

University of Southern California1 site in 1 country228,831 target enrollmentSeptember 22, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Influenza
Sponsor
University of Southern California
Enrollment
228831
Locations
1
Primary Endpoint
Number of Participants Vaccinated at the End of the Campaign Period
Status
Completed
Last Updated
last year

Overview

Brief Summary

Previous studies have shown that low-cost, behavioral nudges through texting can increase influenza vaccination uptake compared to usual care. However, there are limited studies that evaluate the effect of decreasing barriers to scheduling, especially within safety net populations. The setting for this study, DHS, is the second largest public delivery system in the country and serves approximately half a million diverse patients that are eligible for vaccinations annually. This pilot study (one arm in a larger randomized controlled trial) will examine the effect of text messages highlighting MediCal health plan transportation resources (vs standard text messaging) on influenza vaccination rates in adults during the 2022-2023 flu season.

Registry
clinicaltrials.gov
Start Date
September 22, 2022
End Date
June 1, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Daniella Meeker

Associate Professor

University of Southern California

Eligibility Criteria

Inclusion Criteria

  • Los Angeles County Department of Health Services (LACDHS) primary care patients over 6 months of age

Exclusion Criteria

  • LACDHS patients less than 6 months of age

Outcomes

Primary Outcomes

Number of Participants Vaccinated at the End of the Campaign Period

Time Frame: 6 months

Number of Participants who received their influenza vaccination during the campaign period, as measured in the California Immunization Registry (CAIR2) to include vaccinations occurring both inside and outside the LADHS system. We assessed baseline vaccination status at the beginning of the flu season and excluded individuals who already received their vaccination.

Secondary Outcomes

  • Heterogeneity of Treatment Effects for Demographics(6 months)

Study Sites (1)

Loading locations...

Similar Trials